A Study of Revlimid in the Treatment of Non-Hodgkin's Lymphoma

Clinical trial NCT00413036 · COMPLETED

Trial details

NCT number: NCT00413036
Sponsor: Celgene
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphoma, Non-Hodgkin's

Start date: 2006-06-01
Primary completion: 2011-04-01
Enrollment: 217

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.